On Sunday, Ramaphosa announced that South Africa would pull two million doses of the Johnson & Johnson vaccine following contamination concerns at one of the company s sites in the United States.
The South African Health Products Regulatory Authority (SAHPRA) said in a statement that it had decided not to release vaccine produced using the drug substance batches that were not suitable .
Board chairperson of the South African Health Products Regulatory Authority (Sahpra), Helen Rees, said they re concerned about whether all the jabs would still be used if the US regulator did not give approval in time.